Global Cancer Surgery: pragmatic solutions to improve cancer surgery outcomes worldwide

Globally, cancer is the second leading cause of death, and low‐ and middle‐income countries bear most of the disease burden. While cancer is increasingly recognized as a major global health issue, more work remains. Understanding the status of global cancer care will shape the next steps in ensuring equitable global access to cancer care. This article highlights ongoing initiatives in global oncology and the next steps in advancing the field.

Section: Infrastructure Development In Global Oncologymentioning

confidence: 99%

Updates in global oncology: Advancements and future directions

Jackman,

Yibrehu,

Doyle

et al. 2024

“…The greatest increase in demand will occur in low‐ and middle‐income countries (LMICs). Nations are projected to lose 0.5%–1.5% of their annual gross domestic product between 2015 and 2030 if systems for surgical cancer care are not strengthened 4,5 . In this article, we highlight progress made and gaps that still need to be addressed at global and local levels.…”

Section: Introductionmentioning

confidence: 99%

“…The Lancet Commissions in Global Surgery, Global Cancer Surgery part I and now part II made surgery visible in the political sphere 4,5,8 . The Lancet Commission on Global Surgery 2030 laid the groundwork in surgical metrics that could be measured over time.…”

Section: Introductionmentioning

confidence: 99%

“…However, although ministries of health have these NCCP and NSOAP policy plans in place, the actual implementation and improvement in access to surgical care and survival at the ground level has been challenging with minimal progress to date. The Lancet Global Cancer Surgery Commission part II has now laid the groundwork for pragmatic policy solutions and implementation strategies using implementation science framework to improve global cancer surgery that is country and region specific 4 …”

Section: Introductionmentioning

confidence: 99%

“…Cancer surgery is cross disciplinary and is an investment for the entire healthcare system. Operating rooms, inpatient wards, outpatient clinics, and emergency rooms are used for cancer surgery as well as other noncommunicable and communicable diseases 4,5,8 . So, strengthening infrastructure for cancer surgery will strengthen the overall healthcare system and can in turn treat cancer patients as well as other diseases.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Cancer surgery on the global stage: Updates and progress

Murthy,

Are

2023

Self Cite

Over 5 billion people lack access to basic surgical procedures, and it is estimated, the number of surgical procedures needed for cancer care will increase by 5 million from 2018 to 2040. The greatest increase in demand will occur in low‐ and middle‐income countries. In this article, we highlight progress made in surgical cancer care globally and gaps that still needs to be addressed. We highlight political support, workforce progress and shortages, impact of the COVID‐19 pandemic, and the importance of high value cancer care

A Systematic Review and Meta‐Analysis of Oncologic Liver Resections in Low‐ and Middle‐Income Countries: Opportunities to Improve Evidence and Outcomes

Khan,

Mahmud,

Fatimi

et al. 2024

BackgroundPatients in low‐ and middle‐income countries (LMICs) are disproportionately affected by liver cancers but there is a lack of understanding of their postoperative outcomes. This study aimed to review the current status of research in LMICs regarding outcomes after oncologic hepatectomy and synthesize the data reported in the literature.MethodsThe PubMed, Scopus, Embase, Web of Science, and World Health Organization (WHO) Global Index Medicus databases were searched from database inception to May 26th, 2022. Studies that reported outcomes after oncologic hepatectomy in LMIC settings were eligible for inclusion. Two independent reviewers performed record screening and data extraction. Risk of bias assessment was performed using the National Institutes of Health Study Quality Assessment tools. Pooled results with 95% confidence intervals (95% CIs) were calculated using a random effects model.ResultsOne hundred and thirty‐five studies and 16 985 patients were included. Most studies were of a “fair” quality. Two studies described pediatric patients. Only one study was from a low‐income country and most African regions were not represented. The rates of major and minor complications were 11% and 27%, respectively, while 30‐ and 90‐day mortality rates were 2% and 3% each. Postoperative liver failure (8%), surgical site infections (6%), and bile leaks (6%) were common complications.ConclusionsThis review indicates a dearth of data from LMICs on outcomes after hepatectomy, particularly from African regions and low‐income countries.